Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

What symbol and exchange does Zymeworks shares trade?

Zymeworks trades on the NASDAQ stock market under the symbol ZYME.

What is Zymeworks stock price doing today?

As of October 30, 2026, ZYME stock price declined to $28.61 with 542,669 million shares trading.

What is Zymeworks's Beta?

ZYME has a beta of 0.36, meaning it tends to be less sensitive to market movements. ZYME has a correlation of 0.01 to the broad based SPY ETF.

How much is Zymeworks worth?

ZYME has a market cap of $2.06 billion. This is considered a Mid Cap stock.

How much money does Zymeworks make?

Last quarter Zymeworks reported $5 million in Revenue and -$.62 earnings per share. This fell short of revenue expectation by $-14 million and missed earnings estimates by -$.22.

What is the highest and lowest price Zymeworks traded in the last 3 year period?

In the last 3 years, ZYME traded as high as $31.34 and as low as $6.79.

What are the top ETFs holding Zymeworks?

The top ETF exchange traded funds that ZYME belongs to (by Net Assets): VTI, IWM, IBB, IWO, DFAS.

Is Zymeworks (ZYME) a good investment?

ZYME has outperformed the market in the last year with a price return of +49.6% while the SPY ETF gained +12.3%. ZYME has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +26.0% and +14.3%, respectively, while the SPY returned +2.1% and -1.0%, respectively.

What are the support and resistance levels for Zymeworks (ZYME)?

ZYME support price is $27.91 and resistance is $29.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZYME shares will trade within this expected range on the day.